Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06935747Phase 4Not Yet Recruiting

Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

Role: lead

NCT06338241Phase 4Recruiting

Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model

Role: lead

NCT04871256Not ApplicableCompleted

Effects of Septorhinoplasty on Allergic Rhinitis

Role: lead

All 3 trials loaded